Citation: B. Clarkson, REPLY TO COMMENT ON PUBLISHED PAPER - RESPONSE TO MARLEY,SB, LEWIS,JL, GOLDMAN,JM AND GORDON,MY, Leukemia, 12(3), 1998, pp. 445-445
Citation: B. Clarkson, NEW UNDERSTANDING OF THE PATHOGENESIS OF CML - A PROTOTYPE OF EARLY NEOPLASIA BY DR CLARKSON,BAYARD AND COLLEAGUES - RESPONSE TO BACCARANI,MICHELE, Leukemia, 12(3), 1998, pp. 446-447
Authors:
DICRISTOFANO A
CARPINO N
DUNANT N
FRIEDLAND G
KOBAYASHI R
STRIFE A
WISNIEWSKI D
CLARKSON B
PANDOLFI PP
RESH MD
Citation: A. Dicristofano et al., MOLECULAR-CLONING AND CHARACTERIZATION OF P56(DOK-2) DEFINES A NEW FAMILY OF RASGAP-BINDING PROTEINS, The Journal of biological chemistry, 273(9), 1998, pp. 4827-4830
Authors:
CARPINO N
WISNIEWSKI D
STRIFE A
MARSHAK D
KOBAYASHI R
STILLMAN B
CLARKSON B
Citation: N. Carpino et al., P62(DOK) - A CONSTITUTIVELY TYROSINE-PHOSPHORYLATED, GAP-ASSOCIATED PROTEIN IN CHRONIC MYELOGENOUS LEUKEMIA PROGENITOR CELLS, Cell, 88(2), 1997, pp. 197-204
Citation: D. Wisniewski et al., C-KIT LIGAND STIMULATES TYROSINE PHOSPHORYLATION OF THE C-CBL PROTEININ HUMAN HEMATOPOIETIC-CELLS, Leukemia, 10(9), 1996, pp. 1436-1442
Authors:
WISNIEWSKI D
STRIFE A
BERMAN E
CLARKSON B
Citation: D. Wisniewski et al., C-KIT LIGAND STIMULATES TYROSINE PHOSPHORYLATION OF A SIMILAR PATTERNOF PHOSPHOTYROSYL PROTEINS IN PRIMARY PRIMITIVE NORMAL HEMATOPOIETIC PROGENITORS THAT ARE CONSTITUTIVELY PHOSPHORYLATED IN COMPARABLE PRIMITIVE PROGENITORS IN CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA, Leukemia, 10(2), 1996, pp. 229-237
Authors:
CHENG KD
KURZROCK R
ESTROV Z
LEVITZKI A
KANTARJIAN H
BERAN M
QIU XG
MCBRIDE M
CLARKSON B
TALPAZ M
Citation: Kd. Cheng et al., LEUKEMIA-CELL LINE INHIBITION OF CELL-PROLIFERATION, AUTOPHOSPHORYLATION, KINASE-ACTIVITY, AND INDUCTION OF APOPTOSIS BY TYRPHOSTIN AG1112 AND AG957, Blood, 88(10), 1996, pp. 3512-3512
Authors:
CLARKSON B
STRIFE A
PEREZ A
LAMBEK C
WISNIEWSKI D
Citation: B. Clarkson et al., INTEGRATION OF MOLECULAR AND BIOLOGICAL ABNORMALITIES IN QUEST FOR SELECTIVE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA (CML), Leukemia & lymphoma, 11, 1993, pp. 81-100
Citation: B. Clarkson et A. Strife, CYTOKINETIC CONSIDERATIONS RELEVANT TO DEVELOPMENT OF A SUCCESSFUL THERAPEUTIC STRATEGY IN CHRONIC MYELOGENOUS LEUKEMIA (CML), Leukemia & lymphoma, 11, 1993, pp. 101-107
Authors:
WEISS M
TELFORD P
KEMPIN S
KRITZ A
SOGOLOFF H
GEE T
BERMAN E
SCHEINBERG D
LITTLE C
GAYNOR J
BELANGER C
BERTINO J
ANDREEFF M
MCKENZIE S
CLARKSON B
Citation: M. Weiss et al., SEVERE TOXICITY LIMITS INTENSIFICATION OF INDUCTION THERAPY FOR ACUTELYMPHOBLASTIC-LEUKEMIA, Leukemia, 7(6), 1993, pp. 832-837
Citation: B. Clarkson et A. Strife, LINKAGE OF PROLIFERATIVE AND MATURATIONAL ABNORMALITIES IN CHRONIC MYELOGENOUS LEUKEMIA AND RELEVANCE TO TREATMENT, Leukemia, 7(11), 1993, pp. 1683-1721
Authors:
STRIFE A
PEREZ A
LAMBEK C
WISNIEWSKI D
BRUNO S
DARZYNKIEWICZ Z
CLARKSON B
Citation: A. Strife et al., DIFFERENCES IN THE COMPOSITION AND IN THE EFFICIENCY OF RED-CELL PRODUCTION OF NORMAL AND CML ERYTHROID PROGENITOR POPULATIONS ARE HIGHLIGHTED BY RESPONSE TO HUMAN C-KIT LIGAND, Leukemia research, 17(9), 1993, pp. 799-807
Authors:
WEISS M
BERMAN E
MASLAK P
BERTINO J
CLARKSON B
NICHOLS G
ALVAREZ A
GEE T
SCHEINBERG D
GOLDE D
Citation: M. Weiss et al., RAPID REMISSION INDUCTION THERAPY IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) WITHOUT VINCRISTINE OR PREDNISONE, Blood, 82(10), 1993, pp. 10000056-10000056